Introduction {#S0001}
============

Periodontal health is crucial and requires special attention when performing an orthodontic treatment plan, both in adult and pediatric patients \[[1](#CIT0001)\]. Preserving the integrity of periodontal tissues is one of the main concerns of orthodontics specialists, which has led to the definition of specific hygiene protocols for orthodontic patients \[[2](#CIT0002)\]. Since 1985, the scientific community has been very concerned about the interaction between orthodontic devices and oral bacteria \[[3](#CIT0003),[4](#CIT0004)\]; in fact, the first studies to analyze the oral microbiota and conventional braces (CB) took place in this period. In 2012, Freitas et al. published a systematic review regarding the alteration of the oral microbiota caused by fixed appliances \[[5](#CIT0005)\]. The authors concluded that 'The literature revealed moderate evidence that the presence of fixed appliances influences the quantity and quality of oral microbiota'. However, the authors included papers that analyzed bacteria from appliance surfaces and from oral mucosa, without distinction.

Furthermore, a significant number of studies have been published since 2012. Our review aims to update the research of Freitas et al., focusing on studies that have analyzed the microbiota collected from oral sites and not directly from appliances, and including all appliance types (self-ligating braces, invisalign aligners, sports-mouthguards, and other removable appliances) and not only fixed appliances.

Thus, the clinical research questions were as follows: Do orthodontic appliances influence the quality and quantity of the oral microbiota?What are the effects of orthodontic devices on the different bacterial species in the oral cavity?

Materials and methods {#S0002}
=====================

A search of the keywords Orthodontic appliance\* AND (microbiological colonization OR periodontal pathogen\* OR *Streptococcus mutans* OR *Lactobacillus* spp. OR *Candida* OR *Tannerella forsythia* OR *Treponema denticola* OR *Fusobacterium nucleatum* OR *Aggregatibacter actinomycetemcomitans* OR *Prevotella intermedia* OR *Prevotella nigrescens* OR *Porphyromonas gingivalis*) was conducted in PubMed, PMC, Scopus, Lilacs, Scielo, Cochrane Trial Library, Web of Science. All articles published up to October 2017 were included. The Preferred Reporting Items for Reporting Systematic reviews and the Meta Analyses protocol were adopted for this systematic review \[[6](#CIT0006)\].

During the first phase, all the articles were selected by title and abstract by two of the authors and duplicate exclusion was performed. In the next phase, the full texts of potentially relevant papers were evaluated to determine if they met the eligibility criteria. Articles were selected on the basis of the criteria listed in [Table 1](#T0001). The article selection process is illustrated in [Figure 1](#F0001). Discussions were held to resolve any disagreements; when a resolution could not be found, a third review was consulted. Data extraction from the selected papers was performed independently by two review authors who adopted a template similar to that of Freitas et al. \[[5](#CIT0005)\]. The template was adapted to the necessities of our study and is shown in [Table 2](#T0002) \[[5](#CIT0005)\].10.1080/20002297.2018.1476645-T0001Table 1.Study selection criteria.Inclusion criteriaExclusion criteriaTrials analyzing quantity and/or quality of oral microbiota on oral surfaces of orthodontic patientsAt least 10 patients analyzedAt least two time points for analysis (with at least one before the beginning of treatment)Statistical analysis of resultsAbsence of baseline investigation before appliances placamentComparing microbiota only among different patients and not longitudinally in the same groupPatients with systemic diseasesAntibiotic therapy 3 months before and during the studyNo standardization and training in oral hygieneUse of mouth rinse during investigation*In vitro* or animal studiesCase reports, case series, reviews, author opinions10.1080/20002297.2018.1476645-T0002Table 2.Characteristics of studies included in the review.  ParticipantsCollection time    ReferenceStudy designSample size (male/female)GroupsAgeApplianceT0T1T2T3T4Collection methodsMicrobial analysis methodsQuality of the studyAl-Anezi \[9\]RCT (cross-arch)241Mean: 12.6 years ± 1.01 monthSL braces + elastomeric modulesBefore bonding3 months   Sterile paper points from the lateral incisors ligated with and without elastomeric modulesPCR + DGGEBAlves et al. \[10\]RCT (split mouth)14 (6 M/8 F)1Mean: 17 years ± 2.6 monthsCB/Steel ligatures vs. CB/elastomeric ringsBefore bonding6 months   Sterilized periodontal curette 2 mm supragingival and 2 mm subgingivalPCRBArab et al. \[12\]Prospective study30 (6 M/24 F)112--18 yearsCBBefore bonding6 weeks12 weeks18 weeks Saliva collected by spitting into a sterile test tube for 10 minNumber CFU/ml was quantifiedBArikan et al. \[11\]RCT38 (20 M/18 F)2\
G1 (fixed): 9 M/10 F\
G2 (removable): 11 M/8 F4--10 yearsFixed and removable space maintainersBefore appliance of maintainers1 month3 months6 months Sterile foam pads soaked in Sabouraud's broth on six mucosal surfaces*Candida*: colonies were counted separately for each site by visual examination and expressed as CFU/mm^2^\
*E. faecalis*: counted macroscopically based on characteristic gram-stain morphology and recorded as CFU/ml of the original saliva sampleBArslan et al. \[13\]Prospective study42 (23 F/19 M)1Mean: 19.8 yearsCB1 month before bonding1 month6 months12 months Samples taken from saliva, enamel surfaces of U5 and L5, and U1, and L1 adjacent to the braces with sterile wooden toothpicks (at T0 samples only from saliva and not from the teeth)*Candida* identiﬁed by gram-staining, a germ-tube test, chlamydospore, and an API 20C AUX system (Bio-Mérieux, Marcyl'Etoile, France). *Candida* colonies on the plates were countedBBaka et al. \[14\]RCT (split mouth)20 (20 M)2\
G1: SL braces\
G2: CBMean: 14.2 years ± 1.5 monthsSL braces vs. CB/steel ligatureBefore bonding1 week3 months  Sterilized curettes from the labial surfaces of U2 and L2 left and rightDNA extracted from supragingival plaque samples (Dneasy blood and tissue kit) + real-time PCRBDemling et al. \[15\]Prospective study10 (8 F/2 M)1Mean: 29.0 years ± 4.7 monthsLingual bracesBefore bonding3 months   Samples of gingival crevicular ﬂuid taken using sterile paper points. Buccal and lingual sites of U6 and L6, U4 and L4, U1 and L1. In extraction cases, the U5 and L5 instead of the U4 and L4PCRBDemling et al. \[16\]Prospective study20 (6 M/14 F)1Mean: 22.3 years ± 8.6 monthsLingual bracesBefore bonding4 weeks   Gingival crevicular fluid taken with sterile paper points at labial and lingual sites of U6 and L6, U4 and L4, and U1 and L1. In extraction cases, U5 and L5 instead of U4 and L4DNA extracted with a QIAmp DNA Mini Kit + PCRBD'Ercole et al. \[17\]Prospective study60 (27 M/33 F)1Mean: 9.9 years ± 1.2 monthsSport mouthguardsBefore mouthguard6 months1 year6 months without Stimulate saliva with paraffin wax to chew and saliva collected for 5 min in a measuring cupCFUs of SM counts per milliliter of saliva (CFU/ml) GC saliva-check mutans (GC Corp., Belgium)BFarhadian et al. \[18\]RCT662\
G1: Conventional removable retainers\
G2: Removable retainers containing silver nanoparticlesAge ≤25 yearsConventional removable retainers vs. removable retainers containing silver nanoparticles 1 week after debonding7 weeks after retainer delivery  Swab samples were taken from the maxillary palatal sideNumber of SM CFU was counted with a digital colony counterBForsberg et al. \[19\]RCT (splith mouth)12 (6 M/6 F)112--14 yearsLigature wires vs. elastomeric rings (CB)1 week before bondingBefore bonding4 weeks10 weeksT4: 19 weeks\
T5: 34 weeks\
T6: 61 weeks\
T7: 6 weeks after removalStimulated saliva samples, plaque samples collected with charcoaled points from U2CFU count of SM and LBBGhijselings et al. \[21\]Prospective study24 (10 M/14 F)2\
G1: 10 (4 M/6 F) braces only\
G2: 14 additionally treated with a headgearMean: 14.6 years ± 1.1 monthsCB vs. CB + headgearTb\
G1: Bonding time\
G2: 18 weeks before G1Braces removal3 months follow-up2 years follow-up Supragingival plaque: removed by means of sterile curettes. Subgingival plaque: six sterile medium paper points inserted per site (three mesially and three distally) and kept in place for 10 sTotal number of, respectively, anaerobic and aerobic CFU was counted. Speciﬁc black-pigmented colonies on a nonselective anaerobic plate were countedBHägg et al. \[22\]Prospective study27 (13 M/14 F)1Mean: 15.5 years ± 2.3 monthsCBBefore bondingExamined 3 times during a 3-month follow-upExamined 3 times during a 3-month follow-upExamined 3 times during a 3-month follow-up Imprint culture: sterile plastic foam pads dipped in Sabouraud's broth and placed on the dorsum of the tongue. Oral rinse. Pooled plaqueImprint culture\
Candidal: visual counting CFU\
Yeats: gram-stain, germ tube test, and the API 20C AUX assimilation test\
Oral rinse: *Candida* and *Enterobacteriaceae*: CFU\
Pooled plaque: *Candida* and *Enterobacteriaceae*: CFUCHernández-Solis et al. \[23\]Prospective study6014--10 yearsOrthodontic applianceBefore appliance6 months   Samples taken with a sterile swab rubbed over: oral mucosa and the back of the tonguePCRCIreland et al. \[24\]RCT (split mouth)24111--14 yearsSL braces + bands + bonded molar tubes to contralateral quadrants of the mouth + elastomeric ligature on one U2 bracketPre-bond-up at the molar separator appointment3 monthsJust prior of debonding3 months post-debond1 y post-debondSupragingival plaque samples: on molars (bands and bonds) using sterile curettes and subgingivally using sterile paper points\
U2 (with or without elastomeric ligation): supragingival plaque collected adjacent to the bracket marginsPCR + microarray hybridizationBJurela et al. \[25\]Prospective study322\
G1: 16 CB\
G2: 16 esthetic braces13--30 yearsCB vs. esthetic plastic bracesBefore bonding12 weeks   Saliva samplesPCR + cultivation methodBKim et al. \[26\]Prospective study301Mean: 16.7 years ± 6.5 monthsCBBefore bonding1 week3 months6 months Sterile paper points from the distobuccal gingival crevice of the left U1, the left L1, the mesiobuccal gingival crevice of the left U6, and the left L6PCRBKupietzky et al. \[27\]Prospective study (case control)642\
G1: 32 braces\
G2: 32 control12--15 yearsCBG1: Before bonding\
G2: 2 months before G12 months   Salivary collection and bacterial culture followed manufacturer's instructionsLB and SM CFU were compared with standard densitiesCLara-Carrillo et al. \[28\]Prospective study30 (11 M/19 F)1M mean: 16.5 years ± 3.7 months\
F mean: 16.5 years ± 5.5 monthsCBBefore bonding1 monthsCanine retraction (placement of elastic chain in mouth)Anterior segment retraction (placement of closing loops in mouth) Buccal surface of U6, collected with a Q-tipDentocult-SM + Dentocult-LBBLara-Carrillo et al. \[29\]Prospective study34 (14 M/20 F)1Mean: 16.7 years ± 5.2 monthsCBBefore bonding1 month   Unstimulated saliva from inner mucosa\
Stimulated saliva by chewing\
Sterilized cotton swab on U6SM: Dentocult® SM LB: Dentocult® LBBLeung et al. \[30\]Prospective study27 (14 M/13 F)1Mean: 14.9 yearsCBBefore bondingAt least 4 weeks after (mean 7 weeks)   BEC: sterile cytologic brushes on both cheeks. Plaque samples were obtained on the buccal surfaces of the 4-s premolars. Supragingival and subgingival plaque: removed with a sterile periodontal curettePCR + FISHCLevrini et al. \[31\]RCT77 (52 F/25 M)3\
G1: Invisalign\
G2: CB\
G3: ControlMean: 24.3 yearsInvisalign\
CBBegin of the teatment1 month3 months  Sterile paper point into the deepest part of the gingival sulcus for 30 s. Sites: U6 right (Site 0) and U1 left (Site 1)Real-time PCRBLiu et al. \[32\]Prospective study171Mean: 12.6 yearsCBBefore bonding1 month3 months6 months Sterile probe passed along the supragingival smooth surface of the upper right teethLevels of total viable count, total Streptococci and SM in dental plaque + AP-PCRBLombardo et al. \[33\]RCT20 (15 F/5 M)2\
G1: 10 (8 F/2 M) CB\
G2: 10 (7 F/3 M) lingual bracesG1: Mean: 19.3 years ± 3.6 months\
G2: Mean: 22.3 years ± 3.2 monthsCB vs. lingual bracesBefore bonding4 weeks8 weeks  Stimulated saliva collected by chewing paraffin gum for 5 min and expectorating into a sterile cupColonies were countedBMaret et al. \[34\]Prospective study (case control)95 (56 F/39 M)2\
G1 (32 F/16 M): 48 CB\
G2 (24 F/23 M): 47 control12--16 yearsCB vs. controlBefore bonding6 months   Stimulated saliva samples: chewing paraffin wax until 2 ml of saliva had been collectedSalivary SM and LB: Dentocult® SM strips and Dentocult® LB methodCMattingly et al. \[3\]Prospective study10 (6 M/4 F)112--25 yearsCBT0--T1--T2: Three visits before bonding (distance of 10 days)T3--T4--T5: Three visits after bonding (distance of 10 days)   Plaque samples collected with a sterile dental explorer between bracket base and the gingival marginSM CFU countCMiura et al. \[35\]RCT402\
G1: 20 Fluoride-releasing elastomeric ligature ties\
G2: 20 Conventional elastomeric ligature ties12--20 yearsFluoride-releasing elastomeric ligature ties vs. conventional elastomeric ligature tiesBefore ligatureLigature7 days14 days28 daysSaliva and plaque samples. A sterilized curette was used to collect plaque samples from the area surrounding the ligature ties of the right U2, left U5, left L3, and right L5Number of SM CFUBNalçacı et al. \[36\]Prospective study46 (14 F/22 M)2\
G1: 23 (11 F/12 M) SL braces\
G2: 23 (13 F/10 M) CB11--16 yearsSL braces vs. CBBefore bonding1 week5 weeks  Microbial samples taken from the buccal surfaces of all bonded teethNumber of colonies determined under a stereomicroscopeBOrtu et al. \[56\]Prospective study30 (15 M/15 F)3\
G1: 10 RPE\
G2: 10 McNamara expander\
G3: 10 Controls6--9 yearsRPE vs. McNamara expander vs. controlsBefore initiation of expansion therapy3 months6 months  Whole stimulated saliva, stimulated with paraffin-based sticksCFU of SM and LBBPandis et al. \[38\]RCT322\
G1: CB\
G2: SL bracesMean: 13.6 yearsCB ligated with conventional elastomeric modules vs. SL bracesBefore bonding2--3 months   Collect saliva in the mouth and to expectorate into a chilled empty petri dish approximately 3 ml of salivaSalivary SM and total bacteria were enumerated and analyzed after growth in cultureBPaolantonio et al. \[39\]Prospective study (splith mouth)24 (11 M/13 F)118--22 yearsCB in one dental arch vs. control sitesBefore bonding4 weeks8 weeks12 weeks (removal)4 weeks after removalSupragingival plaque: sterile curette subgingival plaque: insertion of three sterile paper points at the deepest part of each gingival sulcus. Sites: mesiobuccal sites of U6--L6 and distobuccal sites of U2--L2 in both dental archesAgar plates examined for presence of Aa. Definitive identification made on the basis of the methods: Gram-stain, nitrate reduction, production of catalase, urease and indole, growth on MacConkey agar, and fermentation reactions to carbohydratesBPejda et al. \[40\]RCT38 (13 M/25 F)2\
G1: 19 (7 M/12 F) SL braces\
G2: 19 (6 M/13 F) CBMean: 14.6 years ± 2.0 monthsSL braces vs. CBBefore bonding6 weeks12 weeks18 weeks Subgingival plaque samples were obtained at 18 weeks (T3). Supragingival plaque: removed with a probe. Subgingival plaque: collected with a sterile paper point from the periodontal sulcus. Sites: U6 right, U1, U4 left, L6 left, L1 right, L4 leftMicro-Dent test+ PCRBPellegrini et al. \[41\]RCT (split mouth)14 (12: full\
appliances, 2: on maxillary arch only)111.7--17.2 yearsSL braces vs. CB with elastomeric ligaturesBefore bonding1 week5 weeks  Plaque specimens collected from labial surfaces surrounding the brackets of U2 and L2 with a sterilized dental scaler. Saliva collection: chewing gum-shaped paraffin wax tablet chewed for 1--5 minTotal oral Streptococci: mitis salivarius agar\
Bacterial count\
Determination of ATP-driven bioluminescence with the Bac-Titer Glo Microbial Cell Viability Assay KitAPerinetti et al. \[42\]Prospective study21 (11 F/10 M)1Mean: 17.1 years ± 3.3 monthsCBBefore bonding28 days   Subgingival plaque and GCF: three 30 standardized sterile paper strips inserted 1 mm into the gingival crevice. Mesial and distal tooth sites: U3 test (DC), its contralateral (CC), and antagonist (AC) used as controls. CC included in the orthodontic appliance, but not subjected to the orthodontic force; AC free from any appliance.Aa colonization was determined by culture methods, while ALP and AST activities were evaluated spectrophotometricallyBPeros et al. \[43\]Prospective study23112--17 yearsCB + bands + wire ligaturesBefore bonding6 weeks12 weeks18 weeks Chewed bilaterally a piece of paraffin waxSalivary analysis: Cultura incubator and a CRT bacteria test kit for SM and LBBRistic et al. \[44\]Prospective study32 (13 M/19 F)112--18 yearsCB + bandsTX: First appointment T0: 3 weeks before bonding1 month3 months6 months Two sterile paper points in to the deepest part of gingival sulcus. Sites: mesio-vestibular points of subgingival sulcus of: U6 right, U1 left, and U4 left. If one was missing, adjacent tooth from the same group was usedSemiquantative determination of anaerobe colonies using direct counting and density comparison. Subculturing, gram-stain, and identification tests of biochemical reactions: for identification of bacteria speciesBRistic et al. \[45\]Prospective study32 (13 M/19 F)112--18 yearsCB + bandsBefore bonding1 month3 months6 months Two sterile paper points in to the deepest part of gingival sulcus. Sites: mesio-vestibular points of subgingival sulcus of: U6 right, U1 left, and U4 left. If one was missing, adjacent tooth from the same group was usedColonies of bacteria were counted. Subculturing, gram-stain, and identiﬁcation tests of biochemical reactions: used for identiﬁcation of bacterial speciesBSfondrini et al. \[46\]RCT (split mouth)20 (6 M/14 F)1Mean: 23.8 yearsBuccal and lingual braces (same braces) vs. controlBefore bonding1 day7 days30 days Microbiological samples from the brackets and the teeth. Supragingival dental plaque: sterile curettesTotal CFU, SM CFU, and anaerobe CFU were measuredBShukla et al. \[47\]RCT60115--25 yearsCBBefore bonding2 months3 months  Plaque samples collected with sterile cotton swab sites: buccal and labial aspects of the anterior teeth and four first molarsCounts of SM were determined by using Dentocult SM kitBShukla et al. \[58\]RCT60113--18 yearsCBBefore bonding2 months3 months  Plaque samples collected with sterile cotton swab sites: buccal and labial aspects of the anterior teeth and four first molarsCounts of SM were determined by using Dentocult SM kit\
*Candida* cultured on Sabouraud's dextrose agarBSinclair et al. \[4\]RCT13 (5 M/8 F)1Mean: 14 years ± 1 monthCB + bandsBefore bonding1 year   Subgingival plaque samples collected with a stainless steel orthodontic wire\
sites: U1--L1 and U6--L6 rightMean counts for the triplicate plates of the five types of medium usedCSudarević et al. \[48\]Prospective study22 (12 F/10 M)1Mean: 25.09 years ± 4.36 monthsCB + elastomeric ligaturesBefore bonding12 weeks   Chewing paraffin wax followed by saliva collectionPCR for SM and *S. sobrinus*CThornberg et al. \[49\]Prospective study190 (47% M/53% F)113.6 yearsCBBefore bonding6 months12 months\>12 months≈3 months after removalSubgingival plaque samples: sterile paper points. Sites: Mesial U6 right, distal U1 right, mesial L6 left, distal l1 left, mesial L4 right (if extracted mesial L5)DNA probe tecniqueCTopaloglu et al. \[50\]Prospective study69 (31 F/38 M)2\
G1: 34 Removable\
G2: 35 CB6--17 yearsCB vs. removable applianceBefore appliance1 month3 months6 months Samples of unstimulated salivaNumbers of CFU per plate were counted.CTorlakovic et al. \[51\]Prospective study20 (8 M/12 F)1Mean: 12 years ± 1 monthCBBefore bonding4 weeks3 months5 months Supragingival plaque samples collected using a sterile Gracey curette\
Sites: Labial surface of U1 right and leftPCR + HOMIMCTurkkahraman et al. \[52\]RCT (split mouth)21 (12 F/9 M)1\
(Two subgroups:\
G1: Elastomeric\
G2: Ligature wires)Mean: 15.37 years ± 3.76 monthsCB + elastomeric rings vs. ligature wiresBefore bonding1 week5 weeks  Microbial samples from labial surfaces of U5Colonies were counted under a stereomicroscopeBTürköz et al. \[53\]Prospective study24114--20 yearsCB and thermoplastic retainers in the retention periodAfter debonding15 days30 days60 days Spit about 5 ml of saliva into 50-ml sterile tubes. Plaque samples collected with sterile swabs from gingival margin and enamel surface of each tooth at vestibule and palatal-lingual sidesTotal viable SM and\
LB colonies were counted -- means of CFUs per milliliter of volume (CFU/ml)BUzuner et al. \[54\]RCT40 (29 F/11 M)2\
G1: 20 CB\
G2: 20 SL braces14--16 yearsCB + steel wire ligature vs. SL bracesBefore bonding1 month   Microbial samples were collected from the stimulated saliva and the plaque from the labial surfaces of the U2--L2, immediately surrounding the orthodontic brackets with a dental scalerTo estimate the number of CFUs of SM and LB, Dentocult SM and LB kits were usedBVan Gastel et al. \[20\]Prospective study24 (10 M/14 F)2\
G1 (headgear): 14 (6 M/8 F)\
G2 (braces only): 10 (4 M/6 F)Mean: 14.6 years ± 1.1 monthHeadgear + bands + CB vs. CBTb\
G1: 18 weeks before G2\
G2: Bonding timeT52\
1 years   Periopaper absorbent strips into the sulcus for 30 s. The mesiobuccal and distobuccal sites of the U4 and U6 right were sampled. In the headgear group, U6 was banded, and U4 was bonded; the samples were analyzed separatelyTotal numbers of anaerobic and aerobic colony CFUs were counted. Pure cultures were identiﬁed by biochemical tests (including *N*-acetylb-[d]{.smallcaps}-glucosaminidase, α-glucosidase, α-galactosidase, α-fucosidase, esculine, indole, and trypsin activity)BWichelhaus et al. \[55\]Prospective study111Mean: 12.7 yearsCBBefore bonding4 weeks12 weeks  Plaque removed from dental surfaces using a sterile curette. Sites: incisors, premolars and molarsPCR -- 13C urea breath tests for HP -- Dentocult® SM -- Dentocult® LBCZheng et al. \[56\]RCT50\
(23 M/27 F)1Mean = 13.6 yearsCBBefore bonding1 month2 months3 months6 monthsGargle methodSamples cultured in CHROMagar *Candida* identiﬁcation. Different *Candida* strains identiﬁed based on the color of the colonies + PCRC[^1]10.1080/20002297.2018.1476645-F0001Figure 1.Article selection process.

Extracted data included first author, year of publication, study design, sample size, age of the patients, type of appliance analyzed, collection time of the study, collection methods, microbial analysis methods, and quality of the study.

Quality analysis {#S0002-S2001}
----------------

The methodological quality is 'the extent to which the design and conduct of a study are likely to have prevented systematic errors (bias)'. Variation in quality can explain variation in the results of studies included in a systematic review. More rigorously designed (better 'quality') trials are more likely to yield results that are closer to the 'truth' \[[7](#CIT0007)\].

The methodological quality of selected papers was scored using the 'Swedish Council on Technology Assessment in Health Care Criteria for Grading Assessed Studies' (SBU) method, which was also used to assess the level of evidence for the conclusions of this review. The SBU method divided the methodological quality of the articles into three grades: grade A -- high value of evidence, grade B -- moderate value of evidence, and grade C -- low value of evidence; once a score had been assigned to each study, the review's level of evidence was stated in four grades: grade 1 -- strong scientiﬁc evidence (at least two studies assessed at level A), grade 2 -- moderate scientiﬁc evidence (one level A study and at least two studies at level B), grade 3 -- limited scientiﬁc evidence (at least two studies at level B), and grade 4 -- insufﬁcient scientiﬁc evidence (fewer than two studies at level B) ([Table 3](#T0003)--[4](#T0004)) \[[8](#CIT0008)\].10.1080/20002297.2018.1476645-T0003Table 3.Swedish council on technology assessment in health-care (SBU) criteria for grading assessed studies.SBU criteria for grading assessed studiesGrade A\
High value of evidence. All criteria should be met: randomized clinical study or a prospective study with a well-defined control group, defined diagnosis and end points, diagnostic reliability tests and reproducibility tests described, blinded outcome assessmentGrade B\
Moderate value of evidence. All criteria should be met: cohort study or retrospective case series with defined control or reference group, defined diagnosis and end points, diagnostic reliability tests, and reproducibility tests describedGrade C\
Low value of evidence. One or more of the conditions below: large attrition, unclear diagnosis, and end points, poorly defined patient material10.1080/20002297.2018.1476645-T0004Table 4.Definitions of evidence level.LevelEvidenceDefinition1StrongAt least two studies assessed with level 'A'2ModerateOne study with level 'A' and at least two studies with level 'B'3LimitedAt least two studies with level 'B'4InconclusiveFewer than two studies with level 'B'

Results {#S0003}
=======

From the initial 588 articles, 51 were selected \[[3](#CIT0003),[4](#CIT0004),[9](#CIT0009)--[57](#CIT0057)\].

Quality of evidence {#S0003-S2001}
-------------------

In 37 of the 52 articles presented with moderate methodological quality \[[9](#CIT0009)--[21](#CIT0021),[24](#CIT0024)--[26](#CIT0026),[28](#CIT0028),[29](#CIT0029),[31](#CIT0031)--[33](#CIT0033),[35](#CIT0035)--[39](#CIT0039),[41](#CIT0041)--[46](#CIT0046),[51](#CIT0051)--[53](#CIT0053),[56](#CIT0056),[57](#CIT0057)\], the major concern was the absence of repeatability tests. One article had a high quality \[[40](#CIT0040)\] and the remaining 13 papers were classified as having a low quality \[[3](#CIT0003),[4](#CIT0004),[22](#CIT0022),[23](#CIT0023),[27](#CIT0027),[30](#CIT0030),[34](#CIT0034),[47](#CIT0047)--[50](#CIT0050),[54](#CIT0054),[55](#CIT0055)\]. Due to the lack of homogeneity in the study settings, a meta-analysis could not be applied and a systematic review realized.

CB {#S0003-S2002}
--

Of the 29 articles that studied CB \[[3](#CIT0003),[4](#CIT0004),[10](#CIT0010),[12](#CIT0012),[13](#CIT0013),[19](#CIT0019)--[23](#CIT0023),[26](#CIT0026)--[30](#CIT0030),[32](#CIT0032),[34](#CIT0034),[35](#CIT0035),[38](#CIT0038),[41](#CIT0041),[44](#CIT0044),[46](#CIT0046)--[48](#CIT0048),[50](#CIT0050),[51](#CIT0051),[54](#CIT0054),[44](#CIT0044),[57](#CIT0057)\], the majority showed a significant increase in BOP and PI. Two studies \[[10](#CIT0010),[52](#CIT0052)\] investigated the differences between the use of elastomeric or steel ligatures, revealing contradictory results on BOP and PI at different times. Ristic's studies \[[44](#CIT0044),[45](#CIT0045)\] highlighted that maximum values of PI and BOP were reached 3 months after appliance placement, followed by a decrease in these parameters 6 months after treatment began. Six studies assessed the increase of *Candida* at different times \[[12](#CIT0012),[13](#CIT0013),[22](#CIT0022),[23](#CIT0023),[56](#CIT0056),[57](#CIT0057)\].

Twenty studies highlighted the increase of gram-positive bacteria, in particular *S. mutans* and *Lactobacillus* spp. \[[3](#CIT0003),[4](#CIT0004),[12](#CIT0012),[19](#CIT0019)--[21](#CIT0021),[27](#CIT0027)--[30](#CIT0030),[32](#CIT0032),[34](#CIT0034),[35](#CIT0035),[42](#CIT0042),[46](#CIT0046),[47](#CIT0047),[50](#CIT0050),[51](#CIT0051),[54](#CIT0054),[57](#CIT0057)\]. Three studies \[[43](#CIT0043),[44](#CIT0044),[48](#CIT0048)\] detected significant increases of gram-negative bacteria, respectively, at 3 and 6 months, followed by a decrease at 6 and 12 months. Ten studies \[[10](#CIT0010),[20](#CIT0020),[21](#CIT0021),[26](#CIT0026),[30](#CIT0030),[37](#CIT0037),[41](#CIT0041),[43](#CIT0043),[44](#CIT0044),[48](#CIT0048)\] detected an increase in the percentage of gram-bacteria and *A. actinomycetemcomitans*. The study conducted by Alves de Souza et al. \[[10](#CIT0010)\] revealed a significant increase in gram-species with the use of elasticomeric rings ([Table 5](#T0005)).10.1080/20002297.2018.1476645-T0005Table 5.Conventional braces results.ReferencePIBOPMicrobiological analysisAlves et al. \[10\]Elastomeric rings:\
Value (T0) = 37.72%; value (T1) = 63.72%\
Steel ligatures:\
Value (T0) = 37.72%; value (T1) = 51.09%Elastomeric rings:\
Value (T0) = 4.28%; value (T1) = 12.28%\
Steel ligatures:\
Value (T0) = 3.86%; value (T1) = 6.71%T0 steel ligatures-elastomeric rings:\
*P*(Aa) = 0.3173; *P*(Tf) = 0.1797; *P*(Pg) = /; *P*(Pi) = /; *P*(Pn) = 1.000\
T1 steel ligatures-elastomeric rings:\
*P*(Aa) = 0.3173; *P*(Tf) = 0.0039; *P*(Pg) = /; *P*(Pi) = 0.5637; *P*(Pn) = 0.0339\
T0--T1 elastomeric rings:\
*P*(Aa) = 0.5637; *P*(Tf)\<0.0001; *P*(Pg) = /; *P*(Pi) = 1,000; *P*(Pn)\<0.0001\
T0--T1 steel ligatures:\
*P*(Aa) = 0.5637; *P*(Tf) = 0.0003; *P*(Pg) = /; *P*(Pi) = /; *P*(Pn) = 0.0003Arab et al. \[12\]  Salivary SM:\
*P*(T0) = /; *P*(T1) \< 0.001; *P*(T2) \< 0.001; *P*(T3) \< 0.001\
Lactobacillus acidophilus:\
*P*(T0) = /; *P*(T1) \< 0.001; *P*(T2) \< 0.001; *P*(T3) \< 0.001\
*Candida albicans*:\
*P*(T0) = /; *P*(T1) \< 0.001; *P*(T2) \< 0.001; *P*(T3) \< 0.001Arslan et al. \[13\]  Saliva: (T0--T1--T2--T3); *P* value \<0.001\
U arch: (T1--T2--T3); *P* value \<0.001\
L arch: (T1--T2--T3); *P* value \<0.001Forsberg et al. \[19\]  No. of bacteria:\
Elastomeric vs. steel:\
T2: 0.21; T3: 0.21; T4: 0.22; T5: 0.10; T6: 0.21\
SM:\
T2: \<0.01; T3: \<0.01; T5: \<0.001; T6: \<0.01\
Aerobic lactobacilli:\
T2: \<0.05; T4: \<0.001; T5: \<0.05; T6: \<0.01\
Anaerobic lactobacili:\
T2: \<0.01; T3: \<0.01; T4: \<0.01; T5: \<0.001; T6: \<0.001Hägg et al. \[22\]T0--T1--T2: *P* \< 0.05 *Candida: P* \< 0.001 after FOA with imprinted technique but not with oral rinse of pooled plaque techniques\
Predominant *Candida* species isolated was *C. albicans*. Number of coliform carriers after FOA --in oral rinse: *P* \< 0.05, in pooled plaque: *P* \< 0.05\
Eight Coliform species after FOA instead of three species before FOAHernández-Solis et al. \[23\]  T0--T1: *P* \< 0.001\
T0: Most frequently found species *C. albicans* (8.3%); T1: *C. tropicalis* (20.0%)Kim et al. \[26\]  Only significant values:\
*T. forsythia*:\
T2 vs. T3:\
U6: 0.013\*; L6: 0.039\*\
T2 vs. T4:\
U6: 0.002\*\*; L1: 0.003\*\*; L6: 0.012\*\
T3 vs. T4:\
L1: 0.021\*\
*C. rectus*:\
T1 vs. T2:\
U6: 0.007\*\*\
*P. nigrescens*:\
T1 vs. T2:\
U6: 0.013\*; L6: 0.022\*Kupietzky et al. \[27\]G2 (control): mean − (SD)+\
T0: 39--16; T1: 34--11\
G1: mean − (SD)+\
T0: 28--6; T1: 30--11\
Pretest differences:\
*P*: 0.001 SM CFU:\
G2 (control): mean − (SD)+\
T0: 2.5--1.2; T1: 2.8--0.9\
G1: mean − (SD)+\
T0: 2.9--0.9; T1: 3.3--0.8\
Pretest differences:\
*P*: 0.09\
LB CFU:\
G2 (control): mean − (SD)+\
T0: 1.8--1.1; T1: 2.3--1.1\
G1: mean − (SD)+\
T0: 2.9--1.2; T1: 3.5--0.7\
Pretest differences:\
*P*: 0.0003Lara-Carrillo et al. \[28\]O'Leary's plaque index: *P* = 0.061 SM:\
T0 (M/F): *P* = 0.852; T1 (M/F): *P* = 0.575; T2 (M/F): *P* = 0.743; T3 (M/F): *P* = 0.867\
LB:\
T0 (M/F): *P* = 0.412; T1 (M/F): *P* = 0.702; T2 (M/F): *P* = 0.428;T3 (M/F): *P* = 0.420Lara-Carrillo et al. \[29\]44.6%, M slightly greater plaque percentage (50.84%) than F (40.15%) (*P* = 0.1809) SM:\
T0: 14/34 subjects had high values (\>10^5^); T1: 16/34 had high values\
LB: T0: 7/34 subjects had high levels (\>10^5^); T1: 20/34 subjects same level, although statistically significant differences were not observed in this distribution (*P* = 0.6905)\
Distribution of bacterial markers, plaque pH, and occult blood in saliva by gender in the study:\
Salivary markers:\
Unstimulated saliva:\
*P*(M/F): 0.3903/0.0026\*; *P*(T0--T1): 0.4073\
Stimulated saliva (ml/min):\
*P*(M/F): 0.0019\*/0.0835; *P*(T0--T1): 0.0001\*\
Buffer capacity:\
*P*(M/F): 0.0381\*/0.1247; *P*(T0--T1): 0.0359\*\
Salivary pH:\
*P*(M/F): 0.1672/0.7039; *P*(T0--T1): 0.0246\*Leung et al. \[30\]  Supragingival and subgingival plaque total DNA after appliance placement: *P* = 0.005\
*Supragingival streptococci: P* = 0.0002\
Buccal cells:\
*A. actinomycetemcomitans: P* = 0.0058Liu et al. \[32\]  Total viable microflora:\
T0: log10 CFU ± SD: 6.94 ± 0.51; T1: log10 CFU ± SD: 7.54 ± 0.46\*\*; T2: log10 CFU ± SD: 7.72 ± 0.36\*\*; T3: log10 CFU ± SD: 8.07 ± 0.44\*\*\
Significance: 0.0001\
S:\
T0: log10 CFU ± SD: 5.61 ± 0.54; T1: log10 CFU ± SD: 6.34 ± 0.65\*\*; T2: log10 CFU ± SD: 6.66 ± 0.57\*\*; T3: log10 CFU ± SD: 6.61 ± 0.55\*\*\
Significance: 0.0001\
SM:\
T0: log10 CFU ± SD: 4.42 ± 0.62; T1: log10 CFU ± SD: 5.42 ± 0.68\*\*; T2: log10 CFU ± SD: 5.42 ± 0.57\*\*; T3: log10 CFU ± SD: 5.68 ± 0.65\*\*\
Significance: 0.0001Maret et al. \[34\]  CB was an independent risk factor for high levels of SM and LB spp. (adjusted OR: 6.65, 95% CI \[1.9822.37\]; 9.49, 95% CI \[2.57--35.07\], respectively)Mattingly et al. \[3\]  T0/T1/T2 vs. T3/T4/T5: *P* \< 0.01\
T3 vs. T5: *P* \< 0.01Paolantonio et al. \[39\]T0--T1: test: *P* \< 0.001; control: *P* \< 0.05\
T1--T2: test: *P* \< 0.05; control: *P* \> 0.1\
T2--T3: test: *P* \> 0.1; control: *P* \> 0.1\
T3--T4: test: *P* \< 0.001; control: *P* \> 0.1\
Overall T0--T4: test: *P* \< 0.05; control: *P* \< 0.05T0--T1: test: *P* \< 0.001; control: *P* \< 0.05\
T1--T2: test: *P* \< 0.05; control: *P* \> 0.1\
T2--T3: test: *P* \> 0.1; control: *P* \> 0.1\
T3--T4: test: *P* \< 0.001; control: *P* \> 0.1\
Overall T0--T4: test: *P* \< 0.05; control: *P* \< 0.05Mean percent of Aa+ sites:\
T0--T1: test: *P* \< 0.001; control: --\
T1--T2: test: *P* \> 0.1; control: *P* \> 0.1\
T2--T3: test: *P* \> 0.1; control: --\
T3--T4: test: *P* \< 0.001; control: --\
Overall T0--T4: test: *P* \< 0.001; control: *P* \> 0.05\
Mean Aa proportion:\
T0--T1: test: *P* \< 0.001; control: *P* \> 0.05\
T1--T2: test: *P* \> 0.05; control: --\
T2--T3: test: *P* \> 0.05; control: --\
T3--T4: test: *P* \< 0.01; control: *P* \> 0.1\
Overall T0--T4: test: *P* \< 0.001; control: *P* \> 0.05Perinetti et al. \[42\]DCs:\
Baseline-28 days: mesial: *P* \< 0.05; distal: *P* \< 0.05\
CCs:\
Baseline-28 days: mesial: *P* \< 0.05; distal: *P* \< 0.05\
ACs:\
Baseline-28 days: mesial: NS; distal: NS\
Among groups differences:\
Baseline-28 days: mesial: *P* \< 0.05; distal: *P* \< 0.05; total: *P* \< 0.01DCs:\
Baseline-28 days: mesial: *P* \< 0.05; distal: *P* \< 0.05\
CCs:\
Baseline-28 days: mesial: *P* \< 0.05; distal: *P* \< 0.05\
ACs:\
Baseline-28 days: mesial: NS; distal: NS\
Among groups differences:\
Baseline-28 days: mesial: *P* \< 0.05; distal: *P* \< 0.01; total: *P* \< 0.01Aa subgingival colonization\
DCs:\
Baseline-28 days: mesial: *P* \< 0.01; distal: *P* \< 0.01\
CCs:\
Baseline-28 days: mesial: *P* \< 0.01; distal: *P* \< 0.01\
ACs:\
Baseline-28 days: mesial: NS; distal: NS\
Among groups differences:\
Baseline-28 days: mesial: *P* \< 0.01; distal: *P* \< 0.01; total: *P* \< 0.01Peros et al. \[43\]  SM:\
T0:/; T1: *P* \< 0.05; T2: *P* \< 0.05; T3: *P* \< 0.05\
LB:\
T0:/; T1: *P* \< 0.05; T2: *P* \< 0.05; T3: *P* \< 0.05Ristic et al. \[44\](mean ± SD)\
Incisors:\
T*x*: 1.281 ± 0.310; T0: 0.898 ± 0.329; T1: 1.211 ± 0.278; T2: 1.250 ± 0.336; T3: 1.219 ± 0.275\
Premolars:\
T*x*: 0.883 ± 0.298; T0: 0.547 ± 0.314; T1: 0.984 ± 0.126; T2: 1.055 ± 0.198; T3: 1.031 ± 0.123\
Molars:\
T*x*: 0.930 ± 0.366; T0: 0.625 ± 0.354; T1: 1.117 ± 0.277; T2: 1.109 ± 0.219; T3: 1.070 ± 0.264(mean ± SD)\
Incisors:\
T*x*: 0.516 ± 0.416; T0: 0.266 ± 0.269; T1: 1.320 ± 0.586; T2: 1.336 ± 0.677; T3: 1.383 ± 0.453\
Premolars:\
T*x*: 0.320 ± 0.366; T0: 0.148 ± 0.236; T1: 0.664 ± 0.379; T2: 0.672 ± 0.394; T3: 0.594 ± 0.415\
Molars:\
T*x*: 0.234 ± 0.304; T0: 0.227 ± 0.249; T1: 0.594 ± 0.358; T2: 0.602 ± 0.347; T3: 0.547 ± 0.367Difference between frequency of bacteria types\
Number determined in different periods of control:\
Incisors:\
T0--T1: *P* \> 0.05; T0--T2: *P* \< 0.01; T0--T3: *P* \> 0.05; T1--T2: *P* \< 0.05; T1--T3: *P* \> 0.05; T2--T3: *P* \> 0.05\
Premolars:\
T0--T1: *P* \> 0.05; T0--T2: *P* \< 0.01; T0--T3: *P* \> 0.05; T1--T2: *P* \> 0.05; T1--T3: *P* \> 0.05; T2--T3: *P* \< 0.01\
Molars:\
T0--T1: *P* \< 0.05; T0--T2: *P* \< 0.01; T0--T3: *P* \> 0.05; T1--T2: *P* \< 0.05; T1--T3: *P* \> 0.05; T2--T3: *P* \> 0.05\
Difference between frequency findings of *P. intermedia* isolated in different periods of control:\
Incisors:\
T0--T1: *P* \> 0.05; T0--T2: *P* \< 0.01; T0--T3: *P* \> 0.05; T1--T2: *P* \< 0.05; T1--T3: *P* \> 0.05; T2--T3: *P* \< 0.05\
Premolars:\
T0--T1: *P* \> 0.05; T0--T2: *P* \> 0.05; T0--T3: *P* \> 0.05; T1--T2: *P* \> 0.05; T1--T3: *P* \> 0.05; T2--T3: *P* \> 0.05\
Molars:\
T0--T1: *P* \> 0.05; T0--T2: *P* \> 0.05; T0--T3: *P* \> 0.05; T1--T2: *P* \> 0.05; T1--T3: *P* \> 0.05; T2--T3: *P* \< 0.05Ristic et al. \[45\]  Total bacterial count compared between different recording periods on incisors, premolars, and molars:\
Incisors:\
T0--T1: *P* \< 0.01; T0--T2: *P* \< 0.01; T1--T2: *P* \< 0.01; T2--T3: *P* \< 0.05\
Premolars:\
T0--T1: *P* \< 0.01; T0--T2: *P* \< 0.01; T1--T2: *P* \< 0.05; T2--T3: *P* \> 0.05\
Molars:\
T0--T1: *P* \< 0.01; T0--T2: *P* \< 0.01; T1--T2: *P* \< 0.05; T2--T3: *P* \> 0.05\
The signiﬁcance of difference between positive ﬁndings of *Prevotella intermedia*:\
Incisors: *P* = 0.003; Premolars: *P* = 0.037; Molars: *P* = 0.022Shukla et al. \[47\]  *P* = 0.000 (\<0.05)Shukla et al. \[58\]  *Candida: P* = 0\
SM: *P* = 0Sinclair et al. \[4\]Plaque index:\
NSGingival index:\
U1: T2--T1: \<0.05; L1: T2--T1: \<0.05; U6: T2--T1: NS; L6: T2--T1: NS\
Mean: T2--T1: \<0.05S: mean: *P* \< 0.01\
Aa: mean: *P* \< 0.05\
Fusobacteria: NS\
Bacteroides: NS\
Spirochetes: NSSudarević et al. \[48\]  SM: T1--T2: NS\
*S. sobrinus*: T2: 2 ptThornberg et al. \[49\]  Comparison of high pathogen counts at T0 to T1, T2, T3, and T4 (significant values)\
*Prevotella intermedia*:\
T0 vs. T1: 0.0001\*\
*Tannerella forsythia*:\
T0 vs. T1: 0.0258\*\
*Eikenella corrodens*:\
T0 vs. T1: 0.0001\*; T0 vs. T3: 0.0051\*; T0 vs. T4: 0.0349\*\
*Fusobacterium nucleatum*:\
T0 vs. T1: 0.0004\*; T0 vs. T3: 0.0206\*; T0 vs. T4: 0.0335\*\
*Treponema denticola*:\
T0 vs. T1: 0.0002\*; T0 vs. T3: 0.0441\*\
*Campylobacter rectus*:\
T0 vs. T1: 0.0225\*; T0 vs. T4: 0.0349\*Topaloglu et al. \[50\]  Means and standard deviations of SM\
Expressed as log10 CFU\
a,c*P* \< 0.05, b,d*P* \> 0.05\
G1:\
SM (T0): 4.4 ± 1.1a,b; SM (T1): 4.0 ± 1.4°; SM (T2): 4.4 ± 1.1°; SM (T3): 5.2 ± 0.6b\
G2:\
SM (T0): 4.1 ± 1.0c,d; SM (T1): 4.2 ± 1.3c; SM (T2): 4.4 ± 1.0c; SM (T3): 5.5 ± 1.0d\
Means and standard deviations of LB spp. expressed as log10 CFU\
a,c*P* \< 0.05, b,d*P* \> 0.05:\
G1:\
LB (T0): 5.6 ± 1.2a,b; LB(T1): 5.4 ± 1.4°; LB (T2): 5.8 ± 1.3°; LB(T3): 6.6 ± 0.7b\
G2:\
LB (T0): 5.7 ± 1.0c,d; LB (T1): 5.9 ± 1.4c; LB (T2): 6.0 ± 1.1c; LB (T3): 6.3 ± 0.6dTorlakovic et al. \[51\]Plaque levels increase: NSPrevalence of gingivitis at U1 increased from T0: 25% to T3: 74%NSTurkkahraman et al. \[52\]Bonded bracket plaque index:\
G1--G2: NS\
T0--T1: *P* \< 0.001; T0--T2: *P* \< 0.001T0 and T1: G1 ≈ G2\
T2: Signiﬁcantly more bleeding in G2Statistical comparison of bacterial counts of the groups:\
Total bacteria: NS\
Anaerobe lactobacilli: NS\
Longitudinal changes in bacterial counts of bonded:\
Total bacteria:\
T0--T1: *P* \< 0.001; T0--T2: *P* \< 0.001; T1--T2: *P* \< 0.001\
Anaerobe lactobacilli:\
T0--T1: *P* \< 0.001; T0--T2: *P* \< 0.001; T1--T2: *P* \< 0.001\
Aerobe lactobacilli:\
T0--T1: *P* \< 0.001; T0--T2: *P* \< 0.001; T1--T2: *P* \< 0.001\
SM:\
T0--T1: *P* \< 0.001; T0--T2: *P* \< 0.001; T1--T2: *P* \< 0.001Van Gastel et al. \[20\] Banded: T1/T0 = 6.29\*; bonded: T1/T0 = 3.95\*CFU ratio aerobe: anaerobe supragingival\
Banded: T1/T0 = 0.49\*; bonded: T1/T0 = 0.51\*\
CFU ratio aerobe: anaerobe subgingival\
Banded: T1/T0 = 0.25\*; bonded: T1/T0 = 0.27\*Wichelhaus et al. \[55\]API:\
Intensity\
0--25:\
T0 (*n* = 11): number: 3 HP+: 2; T1 (*n* = 9): number: 0 HP+: 0; T2 (*n* = 11): number: 0 HP+: 0\
26--35:\
T0 (*n* = 11): number: 0 HP+: 0; T1 (*n* = 9): number: 2 HP+: 2;T2 (*n* = 11): number: 0 HP+: 0\
36--70:\
T0 (*n* = 11): number: 6 HP+: 6; T1 (*n* = 9): number: 5 HP+: 3; T2 (*n* = 11): number: 9 HP+: 6\
71--100:\
T0 (*n* = 11): number: 2 HP+: 1; T1 (*n* = 9): number: 2 HP+: 0; T2 (*n* = 11): number: 2 HP+: 0SBI:\
API:\
Intensity\
0--10:\
T0 (*n* = 11): number: 4 HP+: 3; T1 (*n* = 9): number: 2 HP+: 2; T2 (*n* = 11): number: 2 HP+: 1\
11--20:\
T0 (*n* = 11): number: 1 HP+: 1; T1 (*n* = 9): number: 0 HP+: 0; T2 (*n* = 11): number: 1 HP+: 1\
21--50:\
T0 (*n* = 11): number: 5 HP+: 4; T1 (*n* = 9): number: 6 HP+: 3; T2 (*n* = 11): number: 6 HP+: 3\
51--100:\
T0 (*n* = 11): number: 1 HP+: 1; T1 (*n* = 9): number: 1 HP+: 0; T2 (*n* = 11): number: 2 HP+: 1LB spp.:\
Prevalence\
\<10^3^:\
TO (*n* = 10): number: 7 HP+: 7; T1 (*n* = 9): number: 3 HP+: 2; T2 (*n* = 11): number: 2 HP+: 2\
10^3^--10^4^:\
T0 (*n* = 10): number: 3 HP+: 2; T1 (*n* = 9): number: 5 HP+: 2; T2 (*n* = 11): number: 4 HP+: 1\
\>10^4^:\
T0 (*n* = 10): number: 0 HP+: 0; T1 (*n* = 9): number: 1 HP+: 1;T2 (*n* = 11): number: 5 HP+: 3\
Streptococci:\
\<10^5^\
T0 (*n* = 10): number: 5 HP+: 4; T1 (*n* = 9): number: 6 HP+: 2; T2 (*n* = 11): number: 9 HP+: 5\
10^5^--10^6^:\
T0 (*n* = 10): number: 3 HP+: 3; T1 (*n* = 9): number: 3 HP+: 3; T2 (*n* = 11): number: 2 HP+: 1\
\>10^6^:\
T0 (*n* = 10): number: 2 HP+: 2; T1 (*n* = 9): number: 0 HP+: 0; T2 (*n* = 11): number: 0 HP+: 0Zheng et al. \[56\]  Prior to treatment:\
(1) *P* = 0.58143; (2) *P* = 0.000785\*; (3) *P* = 0.046811\*; (6) *P* = 0.318954\
After 1 months:\
After 2 months *P* = 0.002619\*; after 3 months *P* = 0.129414; after 6 months *P* = 0.64157\
After 2 months:\
After 3 months *P* = 0.099146; after 6 months *P* = 0.009289\*\
After 3 months:\
After 6 months *P* = 0.289807[^2]

Self-ligating braces {#S0003-S2003}
--------------------

Eigh studies analyzed self-ligating braces (SLB) \[[9](#CIT0009),[14](#CIT0014),[24](#CIT0024),[37](#CIT0037)--[40](#CIT0040),[54](#CIT0054)\]. Two studies \[[14](#CIT0014),[40](#CIT0040)\] revealed no differences for BOP and PI between SLB and CB, while Nalçac et al. and Uzuner et al. \[[54](#CIT0054)\] demonstrated a worsening in SLB. Two studies considered the use of SLB with or without elastomeric rings, observing an increase in gram-concentration \[[24](#CIT0024),[38](#CIT0038)\]. One other study \[[14](#CIT0014)\] showed an increase of *S. mutans* and *Lactobacillus* spp. at 3 months with the use of SLB compared to controls. One study \[[41](#CIT0041)\] showed less *S. mutans* with SLB compared to CB ([Table 6](#T0006)).10.1080/20002297.2018.1476645-T0006Table 6.Self-ligating braces results.ReferencePIBOPMicrobiological analysisAl-Anezi \[9\]*P*(T0) = 0.001--*P*(T1) = 0.002*P*(T0) = 0.125--*P*(T1) = 0.508NSBaka et al. \[14\]Signiﬁcance between T0--T1, T1--T2, T0--T1:\
SL:\
*P*(T0--T2) = 0.000; *P*(T1--T2) = 0.000; *P*(T0--T2) = 0.000\
Steel ligature:\
*P*(T0--T2) = 0.000; *P*(T1--T2) = 0.000; *P*(T0--T2) = 0.000\
Statistical comparison of the difference in the clinical periodontal measurements between groups:\
Intergroup comparison:\
*P* value (T0--T2) = 0.091Signiﬁcance between T0--T1, T1--T2, T0--T1:\
SL:\
*P*(T0--T2) = 0.000; *P*(T1--T2) = 0.000; *P*(T0--T2) = 0.000\
Steel ligature:\
*P*(T0--T2) = 0.000; *P*(T1--T2) = 0.000; *P*(T0--T2) = 0.000\
Statistical comparison of the difference in the clinical periodontal measurements between groups:\
Intergroup comparison:\
*P* value (T0--T2) = 0.871Significance between T0--T2 of the bacterial counts:\
SM:\
SL: *P*(T0--T2) = 0.000; steel ligature: *P*(T0--T2) = 0.000\
*S. sobrinus*:\
SL: *P*(T0--T2) = 0.000; steel ligature: *P*(T0--T2) = 0.000\
*L. casei*:\
SL: *P*(T0--T2) = 0.000; steel ligature: *P*(T0--T2) = 0.000\
*L. acidophilus*:\
SL: *P*(T0--T2) = 0.000; steel ligature: *P*(T0--T2) = 0.000\
Statistical comparisons of the differences in the bacterial counts between groups:\
Intergroup comparison:\
SM: *P* = 0.787; *S. sobrinus*: *P* = 0.104; *L. casei: P* = 0.978;l L acidophilus: *P* = 0.386Ireland et al. \[24\]T0 vs. T1; T0 vs. T2: *P* \< 0.001 Treponema Denticola % over total bacteria\
Molar band:\
T0 vs. T1: *P* \< 0.01; T0 vs. T2: *P* \< 0.05\
Molar bonded tube:\
T0 vs. T1: *P* \< 0.05; T1 vs. T3: *P* \< 0.05Nalçacı et al. \[36\]G1:\
T0: 0.46 ± 0.06; T1: 0.60 ± 0.07; T2: 0.66 ± 0.08\
T0--T1: \*; T0--T2: \*; L T1--T2: \*\
G2:\
T0: 0.41 ± 0.05; T1: 0.60 ± 0.06; T2: 0.94 ± 0.09\
T0--T1: \*; T0--T2: \*; T1--T2:\*\
*P* value:\
T0: 0.511 NS; T1: 0.967 NS; T2: 0.030\*G1:\
T0: 0.08 ± 0.07; T1: 0.11 ± 0.11; T2: 0.13 ± 0.02\
T0--T1: \*; T0--T2: \*; T1--T2: NS\
G2:\
T0: 0.06 ± 0.006; T1: 0.11 ± 0.008; T2: 0.21 ± 0.04\
T0--T1: \*; T0--T2: \*; T1--T2: \*\
*P* value:\
T0: 0.068 NS; T1: 0.092 NS; T2: 0.039\*Total bacteria:\
*P* value:\
T0: 0.877 NS; T1: 0.983 NS; T2: 0.525 NS\
Anaerobe lactobacilli:\
*P* value:\
T0: 0.472 NS; T1: 0.568 NS; T2: 0.738 NS\
Aerobe lactobacilli:\
*P* value:\
T0: 0.471 NS; T1: 0.671 NS; T2: 0.738 NS\
SM:\
*P* value:\
T0: 0.115 NS; T1: 0.070 NS; T2: 0.068 NSPandis et al. \[37\]G1--G2 (T0):\
*P* level: NS\
G1--G2 (T1):\
*P* level: NS Analysis of covariance for the salivary SM counts per milliliter saliva of the subjects included in the study:\
Log-SM: *P* = 0.033\* (only significant value)Pejda et al. \[39\]FMPS:\
T0--T1--T2--T3: NS; G1 vs. G2: NSFMBS during time: (*P* \< 0.031) with 7.9% variability\
Statistically significant difference between T0 and T3 (*P* = 0.05) not influenced by type of bracketsPrevalence of AA in G2 vs. G1: *P* \< 0.001. Average number of detected units of AA:\
G2: 10^4^--10^5^\
G1 \< 10^3^\
Red-complex bacteria (PG, PI, TF, and TD) prevalence: NS in G1 and G2\
Total count of tested species: lower in G1 (2.1 ± 1.2) than G2Pellegrini et al. \[40\]  SL braces -- elastomeric:\
Total bacteria: *P* = 0.032^\*^\
Oral streptococci: *P* = 0.030^\*^\
Number of arches exhibiting grater levels of bacteria and ATP bioluminescence in elastomeric vs. SL braces: total bacteria:\
T1: *P* = 0.028; T2: *P* = 0.074\
Oral S:\
T1: *P* = 0.007; T2: *P* = 0.025\
ATP bioluminescence:\
T1: *P* = 0.028; T2: *P* = 0.074Uzuner et al. \[53\]In SLB group PI values increased significantly (*P* \< 0.05)In SLB group GI values increased significantly (*P* \< 0.05)Comparisons of bacterial colonizations T0--T1:\
LB saliva:\
Group: 0.488; time: 0.577; group × time: 0.457\
SM saliva:\
Group: 0.749; time: 0.341; group × time: 0.923\
SM or LB colonization between the groups: NS[^3]

Lingual braces {#S0003-S2004}
--------------

Four studies analyzed lingual braces (LB) \[[15](#CIT0015),[16](#CIT0016),[33](#CIT0033),[45](#CIT0045)\] and three of these highlighted a worsening of PI and BOP \[[15](#CIT0015),[16](#CIT0016),[33](#CIT0033)\]. Two studies \[[16](#CIT0016),[33](#CIT0033)\] revealed an increase of *S. mutans* and *A. actinomycetemcomitans* after 4 weeks ([Table 7](#T0007)).10.1080/20002297.2018.1476645-T0007Table 7.Lingual braces results.ReferencePIBOPMicrobiological analysisDemling et al. \[15\]Buccal sites:\
T0: 0.1 ± 0.2; T1: 0.1 ± 0.2\
Lingual sites:\
T0: 0.1 ± 0.2; T1: 1.2 ± 1.1Buccal sites:\
T0: 12.4 ± 8.2; T1: 14.3 ± 8.1\
Lingual sites:\
T0: 22.2 ± 19.0; T1: 56.2 ± 31.6AA:\
T0: 5 pt; T1: 4 pt\
PG:\
T0: 1 pt; T1: 2 ptDemling et al. \[16\]Maxilla:\
Labial:\
T0: 0.2 ± 0.5; T1: 0.0 ± 0.1; *P*: 0.223\
Palatal:\
T0: 0.1 ± 0.1; T1: 0.1 ± 0.2; *P*: 0.587\
Mandible:\
Labial:\
T0: 0.2 ± 0.3; T1: 0.1 ± 0.2; *P*: 0.329\
Lingual:\
T0: 0.3 ± 0.3; T1: 1.0 ± 0.7; *P*: 0.001Maxilla:\
Labial:\
T0: 19.9 ± 20.1; T1: 13.5 ± 13.6; *P*: 0.184\
Palatal:\
T0: 25.2 ± 19.2; T1: 22.2 ± 18.9; *P*: 0.608\
Mandible:\
Labial:\
T0: 18.1 ± 17.5; T1: 12.9 ± 16.7; *P*: 0.101\
Lingual:\
T0: 23.4 ± 22.5; T1: 46.2 ± 23.5; *P*: 0.001AA\
T0: 25% pt; T1: 35% pt\
PG\
T0, T1: 5% ptLombardo et al. \[33\]G2:\
T0: 0.47 ± 0.18; T1: 0.56 ± 0.15; T2: 0.59 ± 0.16\
T0--T1: *P* \< 0.05; T1--T2: NS; T0--T2: *P* \< 0.5\
G1:\
T0: 0.42 ± 0.17; T1: 0.52 ± 0.25; T2: 0.43 ± 0.20\
T0--T1: NS; T1--T2: NS; T0--T2: NSG2:\
T0: 0.18 ± 0.13; T1: 0.22 ± 0.07; T2: 0.29 ± 0.19\
T0--T1: NS; T1--T2: NS; T0: T2: *P* \< 0.05\
G1:\
T0: 0.31 ± 0.21; T1: 0.45 ± 0.17; T2: 0.33 ± 0.13\
T0--T1: *P* \< 0.05; T1--T2: *P* \< 0.01; T0--T2: NSSM\
G2:\
T0--T1: NS; T1--T2: NS; T0--T2: *P* \< 0.05\
G1:\
T0--T1: NS; T1--T2: NS; T0--T2: NS\
LB spp. :\
G2:\
T0--T1: NS; T1--T2: NS; T0--T2: NS\
G1:\
T0--T1: NS; T1--T2: NS; T0--T2: NSSfondrini et al. \[46\] NS differences (*P* \> 0.05) in the different groups at different timesTotal CFU/*P* value:\
V--L: 4.65E + 6/0.68; V-control: 5.11E + 7/0.2; L-control: 4.64E + 7/0.41\
S CFU/*P* value:\
V--L: 1.69E + 5/0.43; V-control: 1.11E + 6/0.96; L-control: 9.45E + 5/0.38\
Anaerobe CFU/*P* value:\
V--L: −1.49E + 6/0.3; V-control: 3.00E + 5/0.07; L-control: 1.79E + 6/0.51[^4]

Removable appliances {#S0003-S2005}
--------------------

Six studies analyzed removable devices \[[11](#CIT0011),[17](#CIT0017),[18](#CIT0018),[31](#CIT0031),[49](#CIT0049),[52](#CIT0052)\]. One study analyzed different interceptive removable appliances \[[49](#CIT0049)\], demonstrating an increase in both *S. mutans* and *Lactobacillus* spp.

The invisalign study, conducted by Levrini et al. \[[31](#CIT0031)\], revealed lower values of PI, BOP, and bacterial component at 3 months for the invisalign group.

In the two studies with thermoplastic retainers, Türköz et al. \[[52](#CIT0052)\] showed an increase of *S. mutans* and *Lactobacillus* spp. while Farhadian et al. \[[18](#CIT0018)\] observed that the addition of silver nanoparticles reduced the levels of *S. mutans* after 7 weeks.

In one study \[[11](#CIT0011)\], the use of space maintainers defined an increase in BOP in the number of bacteria and in *Candida*. Furthermore, D'Ercole et al. \[[17](#CIT0017)\] pointed out that the use of sports mouthguards produced an increase in BOP and PI ([Table 8](#T0008)).10.1080/20002297.2018.1476645-T0008Table 8.Removable appliances results.ReferencePIBOPMicrobiological analysisArikan et al. \[11\]G1:\
T0--T1: 0.04; T0--T2: 0.01; T0--T3: 0.34\
G2:\
T0--T1: 0.56; T0--T2: 0.61; T0--T3: 0.27G1:\
T0--T1: 0.09; T0--T2: 0.03; T0--T3: 0.001\
G2:\
T0--T1: 0.98; T0--T2: 0.07; T0--T3: 0.05T0:\
T1:\
Mean *Candida*:\
*P*(G1) = 0.68; *P*(G2) = 0.16\
Total *Candida*:\
*P*(G1) = 0.47; *P*(G2) = 0.19\
T2:\
Mean *Candida*:\
*P*(G1) = 0.003; *P*(G2) = 0.12\
Total *Candida*:\
*P*(G1) = 0.01; *P*(G2) = 0.11\
T3:\
Mean *Candida*:\
*P*(G1) = 0.00; *P*(G2) = 0.04\
Total *Candida*:\
*P*(G1) = 0.00; *P*(G2) = 0.07D'Ercole et al. \[17\]FMPS:\
T0 vs. T2: *P* \< 0.05\*FMBS:\
T0 vs. T2: *P* \< 0.05\*SM:\
T0 vs. T1: NS; T0 vs. T2: NS; T1 vs. T2: NSFarhadian et al. \[18\]  SM count:\
T1: *P* value = 0.586; T2: *P* value = 0.000Levrini et al. \[31\]G1 vs. G2: *P* \< 0.05\
G1(T0) vs. G1(T2): *P* \< 0.05G1 vs. G2: *P* \< 0.05G1 vs. G2: *P* \< 0.05\
G1(T0) vs. G1(T2): *P* \< 0.05Topaloglu et al. \[50\]  Means and standard deviations of SM expressed as log10 CFU a,c*P* \< 0.05, b,d*P* \> 0.05\
G1:\
SM (T0): 4.4 ± 1.1a,b; SM (T1): 4.0 ± 1.4; SM (T2): 4.4 ± 1.1a; SM (T3): 5.2 ± 0.6b\
G2:\
SM (T0): 4.1 ± 1.0c,d; SM (T1): 4.2 ± 1.3c; SM (T2): 4.4 ± 1.0c; SM (T3): 5.5 ± 1.0d\
Means and standard deviations of LB expressed as log10 CFU a,c*P* \< 0.05, b,d*P* \> 0.05:\
G1:\
LB (T0): 5.6 ± 1.2a,b; LB (T1): 5.4 ± 1.4a; LB (T2): 5.8 ± 1.3a; LB (T3): 6.6 ± 0.7b\
G2:\
LB (T0): 5.7 ± 1.0c,d; LB (T1): 5.9 ± 1.4c; LB (T2): 6.0 ± 1.1c; LB (T3): 6.3 ± 0.6dTürköz et al. \[53\]  Mean of LB at T3 (14.49 CFU/ml) higher than at T0, T1, and T2: T0--T3: *P* \< 0.05\
Mean of SM at T1 (43.72 CFU/ml) higher than at T0, T2, and T3: T0--T1: *P* \< 0.05; T1--T2: *P* \< 0.05\
SM and LB scounts in saliva: NS among T0, T1, T2, and T3[^5]

Other appliances {#S0003-S2006}
----------------

Two studies investigated other kinds of orthodontic appliances \[[25](#CIT0025),[56](#CIT0056)\]: one fixed interceptive orthodontic appliance and one esthetic brace. In a study that analyzed fixed interceptive appliances, Ortu et al. \[[56](#CIT0056)\] demonstrated an increase in *S. mutans* and *Lactobacillus* spp. ([Table 9](#T0009)).10.1080/20002297.2018.1476645-T0009Table 9.Other appliances results.ReferencePIBOPMicrobiological analysisJurela et al. \[25\]  SM and *S. sobrinus*: NS\
Total bacteria counts: NSOrtu et al. \[57\]  G3: T0--T1--T2: NS\
Group 1:\
T1--T2: NS; LB (T1--T2): NS; SM (T1--T2): NS\
Statistically significant:\
LB (T1--T0): *P* = 0.011; SM (T1--T0): *P* = 0.005; LB (T2--T0): *P* = 0.007; SM (T2--T0): *P* = 0.006.\
G2: LB (T1--T2): NS\
Statistically significant:\
LB (T2--T0): *P* = 0.006; SM (T2--T0): *P* = 0.004; LB (T1--T0): *P* = 0.01; SM (T1--T0): *P* = 0.006; SM (T1--T2): *P* = 0.03[^6]

Discussion {#S0004}
==========

The present systematic review agreed with the conclusions arrived at by Freitas et al. \[[5](#CIT0005)\], which could be extended to any type of orthodontic appliance. The evidence of the selected sample was of medium-high level due to the lack of error of measurements analysis for the collection of material from oral sites. Though this lack of standardization may influence the outcomes, due to the difficulty in obtaining a high repeatability in this procedure, it would not represent a major concern for the studies' quality. In our sample, the use of orthodontic devices resulted in an increase in oral bacterial counts in patients, with significant differences between appliance type, depending on whether they were removable or not.

Previous studies have assessed the role of biomaterials in the regulation of the oral microbiota \[[58](#CIT0058)\]. As stated by Antonelli et al. \[[59](#CIT0059)\], the simplest surfaces for bacteria to colonize are hard ones as mucous membranes tend to scale off and, therefore, do not guarantee a stable adhesion. The only exception to this is the tongue, which is highly colonized even if it is a mucosal surface because of the irregular surfaces of papillae \[[60](#CIT0060)\]. Consequently, the introduction of a biomaterial into this open system creates a further retentive surface on which bacterial species are able to reproduce and where there is an increased difficulty in maintaining oral hygiene \[[58](#CIT0058)\]. As revealed by the Øilo and Bakken \[[58](#CIT0058)\] literature review, the presence of biomaterials results in an increase in plaque and alterations in the oral microbiota.

Thus, on the basis of these assessments, it seems reasonable to state that the grade of bacterial colonization related to orthodontic appliances is affected by the energy and roughness of the appliance surfaces, as well as their design and dimensions. This may be a key factor in efficiently performing hygiene procedures \[[58](#CIT0058)\].

Another significant variable for microbiota alterations is the amount of time the appliance is worn in the oral cavity, with removable appliances having significantly less impact on oral bacteria than fixed appliances \[[61](#CIT0061)\].

The quantitative alteration of the oral microbiota is related to an increase in clinical parameters, PI and BOP, which are risk indicators for oral pathologies \[[62](#CIT0062)\].

Together with the quantitative change, there is also a qualitative variation; indeed, there is an increase in gram-positive and gram-negative more aggressive bacteria, such as: *S. mutans* and *Lactobacillus* spp. (gram-positive) and *P*. *gingivalis, Tforsythia*, and *T. denticola* (gram-negative); and these bacteria are closely associated with, respectively, enamel and dentin pathologies (e.g. demineralizations or caries) and with periodontal disease \[[63](#CIT0063)\]. Recent papers have highlighted the complexity of periodontal disease etiology, with a special focus on the identity of bacteria which are responsible for this pathology \[[64](#CIT0064)--[66](#CIT0066)\]. Thus, authors have stated that the presence alone of specific micriobial species seems insufficient in causing gingivitis and periodontal disease, and that the change in biofilm equilibrium is another key factor in the development of these diseases \[[64](#CIT0064)--[66](#CIT0066)\]. Oral microbiota alterations registered in orthodontic patients appear to be consistent with the modifications occurring in patients with poor oral hygiene presenting gingivitis and/or periodontal diseases. In addition, orthodontic devices could represent a direct risk factor for periodontal diseases as they are often related to an increase in periodontopathogenic species \[[24](#CIT0024),[34](#CIT0034),[43](#CIT0043),[44](#CIT0044),[48](#CIT0048)\]. However, it seems reasonable to state that the susceptibility of each subject, as well as other factors that may alter the biofilm balance, may play a key role in determining the entity of periodontal sequelae.

Even though changes in the microbial system involve all types of orthodontic appliance, more rapid modifications occur during fixed orthodontic treatment. These alterations may be recorded even 1 month after the beginning of treatment and may lead to a decrease in patients' periodontal health perception \[[41](#CIT0041)\]. Even so, as stated by Perinetti et al. \[[41](#CIT0041)\], the role of subgingival bacteria in periodontal modifications needs to be evaluated together with the action of enzymes activated in response to the stimuli of orthodontic forces.

If it is true that all appliances increase the bacterial component, it is also the case that mobile devices make minor changes as they are removable and can be completely cleaned, resulting in better oral hygiene minimizing retentive artifacts. It should also be emphasized that, of these appliances, the use of mouthguards is limited to a small population and they are carried only for limited periods of time, involving a less pathogenic effect.

Less devastating results from changes in the oral microbiota emerged from studies on functional appliances and on aligners, which are used up to 22 h a day \[[61](#CIT0061)\]. So, it seems more important to be able to remove the appliance and wash both it and the teeth rather than the length of time the device is worn.

In view of the changes in microbiota that occurred with the introduction of biomaterials into the oral cavity, and more specifically of the orthodontic devices, it would be appropriate for patients undergoing dedicated hygiene protocols to keep the oral bacterial charge under control and then to reduce the risk of the carious process and periodontal disease, as evidenced by various authors \[[2](#CIT0002),[67](#CIT0067),[68](#CIT0068)\].

Conclusions {#S0005}
===========

The overall evidence quality level was moderate-to-high, thus significant conclusions could be drawn.Orthodontic appliances significantly influence the oral microbiota, independent of appliance type.Significant alterations of the microbiota were registered 1 month after the start of treatment.Removable appliances had less impact on oral bacteria than fixed ones.Personalized professional and daily hygiene protocols are recommended for orthodontic patients from the beginning of treatment.
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[^1]: RCT: Randomized clinical trial; NS: non significant; SLB: self-ligating braces; PCR: polymerase chain reaction; DGEE: denaturing gradient gel electrophoresis; FISH: fluorescent *in situ* hybridization; AP-PCR: PCR with arbitrary primers; CFU/ml: colony-forming units per milliliter; Aa: *Aggregatibacter actinomycetemcomitans*; Tf: *Tannerella forsythia*; Pg: *Porphyromonas gingivalis*; Pi: *Prevotella intermedia*; Pn: *Prevotella nigrescens*; SM: *Streptococcus mutans*; LB: *Lactobacillus* spp.; HP: *Helicobacter pylori*; FOA: fixed oral appliance; U1: upper central incisor; L1: lower central incisor; U2: upper lateral incisor; L2: lower lateral incisor; U3: upper canine; L3: lower canine; U4: upper first premolar; L4: lower first premolar; U5: upper second premolar; L5: lower second premolar; U6: upper first molar; L6: lower first molar; FMPS: full-mouth plaque score; FMBS: full-mouth bleeding score; V: vestibular; L: lingual; HOMIM: Human Oral Microbe Identiﬁcation Microarray; RPE: rapid palatal expander.

[^2]: / : dental site negative; \**P*\<0.05.

[^3]: PI: Plaque index; BOP: bleeding on probing; SBI: sulcus bleeding index; API: interproximal plaque index. \*\**P*\<0.01;  \**P*\<0.05.

[^4]: PI: Plaque index; BOP: bleeding on probing.

[^5]: PI: Plaque index; BOP: bleeding on probing.

[^6]: PI: Plaque index; BOP: bleeding on probing.
